ABCA7 and Alzheimer disease: Recently, it was revealed that patients with low levels of ABCA7 develop AD neuropathology at a younger age, those with intermediate ABCA7 amounts develop it later, and the patients who developed it very late have high ABCA7 levels, just as the youngest controls, suggesting that ABCA7 acts as a blocker of AD in the early stage of this disease [44].